Pennsylvania 2025_0 Regular Session Status: In Committee 8 D cosponsors

SB 301 — An Act amending the act of September 27, 1961 (P.L.1700, No.699), known as the Pharmacy Act, providing for price disclosure.

Last action — Referred to BANKING AND INSURANCE, Feb. 25, 2025

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the Senate. Introduced February 25, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the Senate.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Stalled 26% · moderate confidence

  • In Committee

    Current position in the legislative process.

  • 8 sponsors

    1 primary, 7 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (8 D).

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Prescription Drug Cost Transparency

Bill Text

Action History

  1. Referred to BANKING AND INSURANCE, Feb. 25, 2025

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 7 co-sponsors · 245 not signed on

Sponsors (1)

Co-sponsors (7)

Not signed on (245)

245 members have not signed on to this bill.

Show all 245 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 301 do?
Prescription Drug Cost Transparency
Who sponsors SB 301?
SB 301 is sponsored by Jay Costa (Democratic), Nick Miller (Democratic), Lindsey M. Williams (Democratic), Vincent J. Hughes (Democratic), Carolyn T. Comitta (Democratic), Sharif Street (Democratic), Art Haywood (Democratic), and Judith L. Schwank (Democratic).
What is the current status of SB 301?
This bill is in committee in the Senate. Introduced February 25, 2025. It must pass committee before a floor vote.
Where can I track SB 301?
Track SB 301 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 301

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 301

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →